search
Back to results

Assessment of the Bioavailability of Iron in Iron Fortified Bouillon Cubes in Healthy Nigerian Women

Primary Purpose

Iron Deficiency Anemia

Status
Completed
Phase
Not Applicable
Locations
Nigeria
Study Type
Interventional
Intervention
Meals prepared with iron fortified cube with Low stabilizer level
Meals prepared with iron fortified cube with Medium stabilizer level
Meals prepared with iron fortified cube with High stabilizer level
Sponsored by
Unilever R&D
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Iron Deficiency Anemia focused on measuring Iron fortification, Bioavailability, Nigeria, Women, Bouillon cubes

Eligibility Criteria

18 Years - 40 Years (Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria:

  • Healthy female Nigerian subjects;
  • Age > 18 and <40 years at screening;
  • Body weight <65 kg;
  • Apparently healthy: no medical conditions which might affect study measurements (judged by study physician);
  • With iron deficiency judged by a serum ferritin concentration of <15µg/L;
  • Reported intense sporting activities ≤ 10h/w;
  • Reported alcohol consumption ≤ 14 units/w;
  • Willing and able to participate in the study;
  • Having given a written informed consent.

Exclusion Criteria:

  • Being an employee of Unilever or the Department of Family, Nutrition and Consumer Science of the Obafemi Alowolo University;
  • Blood donation or significant blood loss over the past 6 months;
  • Being severely anemic (hemoglobin < 8.0 g/dL)
  • Reported use of any medically- or self-prescribed diet;
  • Use of vitamin or mineral supplements and unwillingness to discontinue their use one week prior the study and during the study;
  • Smoking or consuming tobacco in any form, and/or was smoking or consuming tobacco in any form for 6 months preceding the study and/or will be smoking or consuming tobacco in any form, during the study;
  • Is pregnant or will be planning pregnancy during the study period;
  • Is lactating or has been lactating in the 6 weeks before pre-study investigation and/or during the study period;
  • Known gastrointestinal (including helminth infection) or metabolic disorders;
  • Participation in another clinical trial during the last 30 days prior to the beginning of the study;
  • Symptomatic malaria (no blood smear analyses on malaria required)

Sites / Locations

  • Obafemi Owalowo University

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Experimental

Experimental

Arm Label

Low stabilizer level

Medium stabilizer level

High stabilizer level

Arm Description

Meals prepared with iron fortified cube with low stabilizer level

Meals prepared with iron fortified cube with medium stabilizer level

Meals prepared with iron fortified cube with high stabilizer level

Outcomes

Primary Outcome Measures

Iron isotopic composition of the blood at the end of each intervention period
The amount of iron isotopic label in the blood will be related to the low, medium and high stabilizer level in the cubes to determine whether a dose-response relationship exists.

Secondary Outcome Measures

Iron isotopic composition of the blood
The amount of iron isotopic label in the blood at the end of each administration period plus 14 day incorporation time will be used to calculate the absolute Iron absorption for each stabilizer level

Full Information

First Posted
May 24, 2016
Last Updated
July 31, 2017
Sponsor
Unilever R&D
Collaborators
Obafemi Awolowo University
search

1. Study Identification

Unique Protocol Identification Number
NCT02815449
Brief Title
Assessment of the Bioavailability of Iron in Iron Fortified Bouillon Cubes in Healthy Nigerian Women
Official Title
Assessment of the Bioavailability of Iron in Iron Fortified Bouillon Cubes in Healthy Nigerian Women
Study Type
Interventional

2. Study Status

Record Verification Date
July 2017
Overall Recruitment Status
Completed
Study Start Date
May 8, 2017 (Actual)
Primary Completion Date
July 24, 2017 (Actual)
Study Completion Date
July 24, 2017 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Unilever R&D
Collaborators
Obafemi Awolowo University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The prevalence of iron deficiency anemia is a wide spread problem in Africa and iron fortification can be an effective strategy to decrease this. In the current study adding different levels of a stabilizer to iron fortified cubes and it's effect on iron bioavailability from these cubes will be studied in the context of a Nigerian meal in women. 24 Female subjects with low serum ferritin levels will be included in the study. The study will last 64 days and subjects will be asked to consume a breakfast and lunch prepared with a bouillon cube with isotope labeled iron during 3 periods of 5 consecutive days. The absorption of iron will be evaluated after every period and compared between the cubes.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Iron Deficiency Anemia
Keywords
Iron fortification, Bioavailability, Nigeria, Women, Bouillon cubes

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
24 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Low stabilizer level
Arm Type
Experimental
Arm Description
Meals prepared with iron fortified cube with low stabilizer level
Arm Title
Medium stabilizer level
Arm Type
Experimental
Arm Description
Meals prepared with iron fortified cube with medium stabilizer level
Arm Title
High stabilizer level
Arm Type
Experimental
Arm Description
Meals prepared with iron fortified cube with high stabilizer level
Intervention Type
Other
Intervention Name(s)
Meals prepared with iron fortified cube with Low stabilizer level
Intervention Description
Meals prepared with iron fortified cube with Low stabilizer level
Intervention Type
Other
Intervention Name(s)
Meals prepared with iron fortified cube with Medium stabilizer level
Intervention Description
Meals prepared with iron fortified cube with Medium stabilizer level
Intervention Type
Other
Intervention Name(s)
Meals prepared with iron fortified cube with High stabilizer level
Intervention Description
Meals prepared with iron fortified cube with High stabilizer level
Primary Outcome Measure Information:
Title
Iron isotopic composition of the blood at the end of each intervention period
Description
The amount of iron isotopic label in the blood will be related to the low, medium and high stabilizer level in the cubes to determine whether a dose-response relationship exists.
Time Frame
16 days
Secondary Outcome Measure Information:
Title
Iron isotopic composition of the blood
Description
The amount of iron isotopic label in the blood at the end of each administration period plus 14 day incorporation time will be used to calculate the absolute Iron absorption for each stabilizer level
Time Frame
1, 22, 43 and 64 days

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Healthy female Nigerian subjects; Age > 18 and <40 years at screening; Body weight <65 kg; Apparently healthy: no medical conditions which might affect study measurements (judged by study physician); With iron deficiency judged by a serum ferritin concentration of <15µg/L; Reported intense sporting activities ≤ 10h/w; Reported alcohol consumption ≤ 14 units/w; Willing and able to participate in the study; Having given a written informed consent. Exclusion Criteria: Being an employee of Unilever or the Department of Family, Nutrition and Consumer Science of the Obafemi Alowolo University; Blood donation or significant blood loss over the past 6 months; Being severely anemic (hemoglobin < 8.0 g/dL) Reported use of any medically- or self-prescribed diet; Use of vitamin or mineral supplements and unwillingness to discontinue their use one week prior the study and during the study; Smoking or consuming tobacco in any form, and/or was smoking or consuming tobacco in any form for 6 months preceding the study and/or will be smoking or consuming tobacco in any form, during the study; Is pregnant or will be planning pregnancy during the study period; Is lactating or has been lactating in the 6 weeks before pre-study investigation and/or during the study period; Known gastrointestinal (including helminth infection) or metabolic disorders; Participation in another clinical trial during the last 30 days prior to the beginning of the study; Symptomatic malaria (no blood smear analyses on malaria required)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Funke Olumakaiye, PhD
Organizational Affiliation
Obafemi Awolowo University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Obafemi Owalowo University
City
Ile Ife
Country
Nigeria

12. IPD Sharing Statement

Plan to Share IPD
Undecided
Citations:
PubMed Identifier
31004134
Citation
Eilander A, Funke OM, Moretti D, Zimmermann MB, Owojuyigbe TO, Blonk C, Murray P, Duchateau GS. High Bioavailability from Ferric Pyrophosphate-Fortified Bouillon Cubes in Meals is Not Increased by Sodium Pyrophosphate: a Stable Iron Isotope Study in Young Nigerian Women. J Nutr. 2019 May 1;149(5):723-729. doi: 10.1093/jn/nxz003.
Results Reference
derived

Learn more about this trial

Assessment of the Bioavailability of Iron in Iron Fortified Bouillon Cubes in Healthy Nigerian Women

We'll reach out to this number within 24 hrs